Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
Daily Market Overview S And P 500 Nasdaq Up Dow Slips In Mixed Trade 20260403 1 Wall Street Retreats as Inflation Concerns Resurface Jim Cramer Advises Caution on Silicon Motion Buy Some Then Wait for a Pullback Rent the RENT Drops 654 Key Support at 367 20260515 Infosys Oracle Financial Services Tech Mahindra Lead IT Stock Gains Amid Broader Market Weakness US Productivity Growth Moderates in Fourth Quarter as Unit Labor Costs Rise LongTerm AI Investment Potential A Stock to Watch Over the Next Decade Fiserv and OpenAI Forge Strategic Partnership to Embed Frontier AI Into Financial Platforms Vodafone Idea Among Midcap Stocks Reaching 52Week Highs in Recent Rally ASEAN Manufacturers Reduce Workforce Amid Deepening Iran Conflict Impact Fed Cut Hopes Dim as Jobs Data Underscore Sticky Inflation SXT Q1 2026 Earnings Strong EPS Beat Drives Positive Sentiment MSDL Q1 2026 Earnings Small EPS Beat Meets Modest Market Pullback ORIC Q1 2026 Earnings Narrower Loss Misses Estimates as Clinical Development Continues DTG Q1 2026 Earnings EPS Miss Modest Stock Decline Amid Mixed Signals New Found Gold Corp NFGC Q1 2026 Earnings EPS Miss Highlights Exploration Stage Challenges III Q1 2026 Earnings EPS Surpasses Estimates by 17 as Stock Edges Higher Manulife Financial MFC Holds Steady at 3869 as Bulls Eye Resistance TryHard Holdings THH Jumps 74 Testing Key Resistance at 038 AdaptHealth Corp AHCO Declines Slightly Holding Near Key Support Zone Xos Inc XOS Edges Higher but Resistance Caps NearTerm Gains Dolby Laboratories DLB Climbs 12 as Shares Hold Above Key Support Black Stone Minerals Q1 2026 Earnings EPS Misses Estimates Significantly as Royalty Income Falls Short Curis Inc Q1 2026 Earnings Deep EPS Miss as PreRevenue Biotech Continues Development NeoGenomics NEO Q1 2026 Earnings EPS Beats Estimates by 389 Stock Gains ONCY Q3 2025 Earnings WiderthanExpected Loss Amid Clinical Progress NXE Q1 2026 Earnings Wider Than Expected Loss as Development Continues